AI Article Synopsis

  • * A new mutation in the RNF216 gene, specifically p.E650X, has been identified in a patient who exhibited symptoms like speech difficulties, balance issues, cognitive decline, and azoospermia at 28 years old.
  • * The study enhances understanding of the genetic basis of GHS and broadens the knowledge of RNF216 mutations across different ethnic groups.

Article Abstract

Gordon Holmes syndrome (GHS) is a rare disease characterized by hypogonadotropic hypogonadism (HH), progressive cognitive decline and variable movement disorders. Mutations in RNF216 have been found to be associated with GHS. Here, we identify a novel homozygous RNF216 p.E650X mutation causing GHS. The proband presented with onset dysarthria and developed cerebellar ataxia and cognitive impairment, with a history of azoospermia at the age of 28 years. Cerebellar atrophy and white matter lesions were found in the cerebral hemispheres and brainstem. Low gonadotropin serum levels were also observed. Whole-exome sequencing (WES) revealed a novel homozygous nonsense variant in RNF216, c.1948G>T; p.E650X. Our finding furthers the genetic knowledge of GHS and extends the ethnic distribution of RNF216 mutations.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12031-021-01953-0DOI Listing

Publication Analysis

Top Keywords

whole-exome sequencing
8
gordon holmes
8
holmes syndrome
8
novel homozygous
8
rnf216
5
sequencing identified
4
identified novel
4
novel mutation
4
mutation rnf216
4
rnf216 family
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!